MDR multidrug resistance
MDR (multidrug resistance) is a property that first identified in tumor cell, hat the resistance of tumor cell is to a variety of chemotherapy agent due to active efflux via transporter proteins.
Products for MDR multidrug resistance
- Cat.No. Product Name Information
- GC45246 (-)-Chaetominine (-)-Chaetominine is a cytotoxic alkaloid originally isolated from Chaetomium sp.
- GC41865 10'-Desmethoxystreptonigrin 10'-Desmethoxystreptonigrin is an antibiotic originally isolated from Streptomyces and a derivative of the antibiotic streptonigrin.
- GC45324 2,5-dimethyl Celecoxib
-
GC42616
7-oxo Staurosporine
7-oxo Staurosporine is an antibiotic originally isolated from S.
- GC49275 8-Oxycoptisine 8-Oxycoptisine is a natural protoberberine alkaloid with anti-cancer activity.
- GC46809 Afatinib-d6 An internal standard for the quantification of afatinib
- GC42806 Andrastin A Andrastin A is a meroterpenoid farnesyltransferase inhibitor.
-
GC43004
C10 Ceramide (d18:1/10:0)
C10 ceramide is an endogenous, bioactive sphingolipid produced by ceramide synthase.
- GC43060 C2 Adamantanyl Globotriaosylceramide (d18:1/2:0) C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain.
- GC45395 Cabazitaxel-d9 Cabazitaxel-d9 is deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.
- GC45679 Carubicin An anthracycline with anticancer activity
- GC40795 CAY10503 CAY10503 is a proapoptotic, antiproliferative compound that is able to arrest cell cycle progression in the G0-G1 phase.
- GC18901 CAY10647 CAY10647 is an aryl-benzoyl-imidazole which prevents proliferation of multidrug resistant cancer cells in vitro (IC50 = 28-63 nM) and inhibits melanoma xenograph tumor growth in vivo (10-30 mg/kg).
- GC45792 Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) An inducer of ferroptosis
- GC46004 Evoxanthine An alkaloid
- GC49106 Gentisein A xanthone with diverse biological activities
- GC47409 Glycocholic Acid-d4 A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
- GC49670 Indium (III) thiosemicarbazone 5b An anticancer agent
- GC44129 MC 70 A P-glycoprotein inhibitor
- GC48479 Migrastatin A fungal metabolite with antimuscarinic and anticancer activities
- GC44195 Milbemycin A4 oxime Milbemycin A4 oxime is a derivative of milbemycin A4 and a component of milbemycin oxime, compounds that both have insecticidal and nematocidal activity.
- GC41564 MPT0B014 An inhibitor of tubulin polymerization
- GC45784 ONT-093 A P-glycoprotein inhibitor
- GC49251 Oxaliplatin-d10 An internal standard for the quantification of oxaliplatin
- GC44613 PF-6274484 PF-6274484 is an inhibitor of the EGF receptor (EGFR; IC50s = 0.18 and 0.14 nM for wild-type EGFR and inhibitor-resistant EGFRL858R/T790M, respectively).
- GC44615 PGP-4008 PGP-4008 is a selective inhibitor of P-glycoprotein (P-gp) that does not affect the activity of multidrug resistance-related protein 1 (MRP1).
- GC41629 Piperafizine A Piperafizine A is a natural methylated diketopiperazine first isolated from an actinomycete, Streptoverticillium.
- GC52455 Pixantrone-d8 (maleate) An internal standard for the quantification of pixantrone
- GC52104 Ponatinib (hydrochloride) An inhibitor of native and mutant Bcr-Abl
-
GC17403
Pyronaridine Tetraphosphate
An antimalarial agent
- GC44821 Reversin 121 Reversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.
- GC45688 STX140 An estrogen sulfamate
- GC48119 Suprafenacine An inhibitor of tubulin polymerization with anticancer activity
- GC48219 Ulipristal Acetate-d6 An internal standard for the quantification of ulipristal acetate
- GC49308 Ungeremine A betaine-type alkaloid with diverse biological activities